Stock Information
Prime Medicine Inc (PRME)
Ticker Symbol: PRME
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $668.28 mil
Piotroski score: 4
PE Ratio: N/A
EPS (TTM): -1.09
Revenue (TTM): $0.02 M
Dividend Yield: N/A
ROE: -188.27%
Latest News
-
Crispr Therapeutics: Why AI Giant Anthropic's Discovery Has Rocked Gene Editing
Thu, Sep 24, 2026 2:59 PM
-
Anthropic AI Discovery Gene-Editing Stocks Falling
Thu, Sep 24, 2026 12:46 PM
-
CRSP, NTLA, BEAM, PRME, EDIT Shares Slip — Did Claude Just Spook Gene-Editing Stocks?
Wed, Sep 23, 2026 9:49 PM
-
10 Health Care Stocks Whale Activity In Today’s Session
Mon, Sep 21, 2026 1:35 PM
-
In Vivo Gene Editing Market Size, Share & Trends Analysis - Global Opportunity Analysis & Industry Forecast (2026-2036)
Fri, Sep 18, 2026 3:38 PM
-
Gene-Editing Powerhouse And Its Rivals Surge Toward A Breakout
Thu, Sep 17, 2026 8:09 PM
Key Financials
Financial data not available
